Skip to main content
Premium Trial:

Request an Annual Quote

OncoMethylome Raises 3.3M Euros, Bringing IPO Proceeds up to 25.3M Euros

NEW YORK (GenomeWeb News) - Following its initial public offering and Euronext listing on June 27, OncoMethylome Sciences said on Friday that it has raised an additional €3.3 million through the exercise of over-allotment option by Fortis and ING, the joint lead managers in the offering.
 
OncoMethylome granted the option on up to 440,000 new shares, at the IPO price of €7.5 per share.
 
As a result, the company's proceeds from the IPO total €25.3 million.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.